Endra Life SciencesNDRA
13F holders, Q3 2025 (September 30)5holders +2
2new positions
0sold out
$5.38avg. 13F price*
At the end of Q3 2025, 5 institutions reported holding Endra Life Sciences Inc. (NDRA) in their 13F filings, up 2 from Q2 2025. 2 opened new positions and 0 sold out. The largest holders were DRW Securities, LLC ($68K), Tower Research Capital LLC (TRC) ($1K) and UBS Group AG ($570).
- Company
- Endra Life Sciences Inc.
- CUSIP
- 29273B500
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $70K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 12,939 shares bought and 4,589 shares sold, net +8,350 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| DRW Securities, LLC | 0.00% | New | 12,714 | $68K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 225 | $1K |
| UBS Group AG | 0.00% | Reduce -97.7% | 106 | $570 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 35 | $188 |
| Bank of America Corp. | 0.00% | No change | 6 | $32 |
"% of holder's portfolio" is NDRA's weight in each manager's 13F, not the share of Endra Life Sciences Inc. the manager owns.